Alcami Corp.

2320 Scientific Park Drive, Wilmington

No. of employees: About 400 locally and 850 globally
 
Year founded: 1979
 
Top local officials: Amanda Wohlleber, site director of drug product operations in Wilmington, and Katie Schlipp, executive director of analytical services in Wilmington

Company description: Alcami Corp. is a Wilmington-headquartered contract development and manufacturing organization (CDMO) with expertise in drug development from discovery to commercialization.
 
Products made locally: Oral solid dosage drug products including tablets, hard-shell capsules and powders. Additional service offerings include analytical testing and development services of life-changing medications.
 
Product distribution: Global
 
What made the company decide to make its goods locally? Amanda Wohlleber: “The people – our employees here in Wilmington have the passion and expertise to offer a unique value proposition of immense scientific talent and harmonious collaboration with our customers.”
 
What’s your target market? Wohlleber: “We are positioned to serve pharma and biotech companies of all sizes with the ability to stay nimble as the pharmaceutical landscape evolves.”
 
What’s planned next? Wohlleber: “We just completed a $2 million investment at our Wilmington headquarters to expand our oral solid development and manufacturing capabilities with the addition of a Gerteis Mini-Pactor roller compactor and low-humidity suites to our existing 140,000-square-foot campus in Wilmington. The expansion also builds out dry granulation capabilities and offers increased flexibility to support moisture-sensitive processes. Further expansions are planned in Wilmington as we continue to expand our oral solid dose manufacturing, packaging and analytical service offerings in Wilmington.”

EDITOR’S NOTE: To be considered for the Greater Wilmington Business Journal’s MADE feature, contact [email protected].